Stone, Daniel http://orcid.org/0000-0003-1619-7541
Aubert, Martine http://orcid.org/0000-0003-1125-6856
Jerome, Keith R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P30 AI 027757, R21AI117519, R01AI132599, UM1 AI126623)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA015704)
amfAR, The Foundation for AIDS Research
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 28 April 2022
Revised: 12 April 2023
Accepted: 20 April 2023
First Online: 10 May 2023
Competing interests
: KRJ is a paid advisor and holds equity in Excision Biosciences, has sponsored research agreements with Excision Biosciences and Emendo Biotherapeutics, and is co-inventor of patents held by Fred Hutch regarding AAV-delivered gene therapy. DS and MA have sponsored research agreements with Excision Biosciences.